Intraplantar injection of nerve growth factor into the rat hind paw: Local edema and effects on thermal nociceptive threshold

Pain

Volumn 64, Issue 2, 1996, Pages 323-329

  Amann, Rainer ^a   Schuligoi, Rufina ^a   Herzeg, Gernot ^a   Donnerer, Josef ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

capsaicin; compound 48 80; nerve growth factor; neuropeptide; thermal hyperalgesia

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE ANTAGONIST; CAPSAICIN; COMPOUND 48-80; HISTAMINE; INDOMETACIN; NERVE GROWTH FACTOR; NOLPITANTIUM; SUBSTANCE P; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EDEMA; HYPERALGESIA; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029925173     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(95)00120-4     Document Type: Article

References (32)

1. Andreev, N.Y., Dimitrieva, N., Koltzenburg, M. and McMahon, S.B., Peripheral administration of nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones, Pain (1995) in press.
2. Cambridge, H. and Brain, S.D., Calcitonin gene-related peptide increases blood-flow and potentiates plasma-protein extravasation in the rat knee joint, Br. J. Pharmacol., 106 (1992) 746-750.
3. Brain, S.D. and Williams, T.J., Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability, Br. J. Pharmacol., 86 (1985) 855-860.
4. Donnerer, J., Schuligoi, R. and Stein, C., Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo, Neuroscience, 49 (1992) 693-698.
5. Edmonds-Alt, X., Doutremepuich, J.-D., Heaulme, M., Neliat, G., Santucci, V., Steinberg, R., Vilain, P., Bichon, D., Ducoux, J.-P., Proietto, V., Van Broeck, D., Soubrie, P., Le Fur, G. and Breliere, J.-C., In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist, Eur. J. Pharmacol., 250 (1993) 403-413.
6. Eglezos, A., Guiliani, S., Viti, G. and Maggi, C.A., Direct evidence that capsaicin-induced plasma protein extravasation is mediated through tachykinin NK1 receptors, Eur. J. Pharmacol., 209 (1991) 277-279.
7. Gamillscheg, A., Holzer, P., Donnerer, J. and Lembeck, F., Effect of neonatal treatment with capsaicin on carrageenan-induced paw oedema in the rat, Naunyn-Schmiedeberg's Arch. Pharmacol., 325 (1984) 340-342.
8. Gamse, R. and Saria, A., Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene related peptide, Eur. J. Pharmacol., 114 (1985) 61-66.
9. Goedert, M., Stoeckel, K. and Otten, U., Biological importance of the retrograde axonal transport of nerve growth factor in sensory neurons, Proc. Natl. Acad. Sci. USA, 78 (1981) 5895-5898.
10. Hargreaves, K., Dubner, R., Brown, F., Flores, C. and Joris, J., A new and selective method for measuring thermal nociception in cutaneous hyperalgesia, Pain, 32 (1988) 77-88.
11. Holzer, P., Capsaicin: cellular targets, mechanism of action, and selectivity for thin sensory neurons, Pharmac. Rev., 43 (1991) 143-201.
12. Holzer, P., Saria, A., Skofitsch, G. and Lembeck, F., Increase in tissue concentrations of histamine and 5-hydroxytryptamine following capsaicin treatment of newborn rats, Life Sci., 29 (1981) 1099-1105.
13. Horigome, K., Pryor, J.C., Bullock, E.D. and Johnson, E.M., Mediator release from mast cells by nerve growth factor, J. Biol. Chem., 268 (1993) 14881-14887.
14. Jancsó, N., Jancsó-Gábor, A. and Szolcsányi, J., Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin, Br. J. Pharmacol. Chemother., 31 (1967) 138-151.
15. Lewin, G.R and Mendell, L.M., Nerve growth factor and nociception, Trends Neurosci., 16 (1993) 353-359.
16. Lewin, G.R., Ritter, A.M. and Mendell, L.M., Nerve growth factor induced hyperalgesia in the neonatal and adult rat, J. Neurosci., 13 (1993) 2136-2148.
17. Lewin, G.R., Rueff, A. and Mendell, L.M., Peripheral and central mechanisms of NGF-induced hyperalgesia, Eur. J. Neuroscience, 6 (1994) 1903-1912.
18. Ley, Y.H., Barnes, P.J. and Rogers, D.F., Inhibition of neurogenic plasma exudation in the guinea-pig airways by CP-96,345, a new non-peptide NK(1) receptor antagonist, Br. J. Pharmacol., 105 (1992) 261-262.
19. Lindsay, R.M. and Harmar, A.J., Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons, Nature, 337 (1989) 362-362.
20. Mazurek, N., Weskamp, G., Erne, P. and Otten, U., Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels, FEBS Lett., 198 (1986) 315-320.
21. Newbold, P. and Brain, S.D., The modulation of inflammatory edema by calcitonin gene-related peptide, Br. J. Pharmacol., 108 (1993) 705-710.
22. Otten, U., Baumann, J.B. and Girard, J., Nerve growth factor induces plasma extravasation in rat skin, Eur. J. Pharmacol., 106 (1985) 199-201.
23. Saria, A., Hua, X., Skofitsch, G. and Lundberg J.M., Inhibition of compound 48/80 - induced vascular protein leakage by pretreatment with capsaicin and a substance P antagonist, Naunyn-Schmiedeberg's Arch. Pharmacol., 328 (1984) 9-15.
24. Shen, K.F. and Crain, S.M., Nerve growth factor rapidly prolongs the action potential of mature sensory ganglion neurons in culture, and this effect requires activation of Gs-coupled excitatory kappa-opioid receptors on these cells, J. Neurosci., 14 (1994) 5570-5579.
25. Skofitsch, G., Saria, A., Holzer, P. and Lembeck, F., Histamine in tissue: determination by high performance liquid chromatography after condensation with o-phthal-dialdehyde, J. Chromatog., 226 (1981) 53-59.
26. Stoeckel, K., Schwab, M. and Thoenen, H., Specificity of retrograde transport of nerve growth factor (NGF) in sensory neurons: a biochemical and morphological study, Brain Res., 89 (1975) 1-14.
27. Urban, L., Thompson, S.W.N. and Dray, A., Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmitters, Trends Neurosci., 17 (1994) 432-438.
28. Vedder, H., Affolter, H-U., and Otten, U., Nerve growth factor (NGF) regulates tachykinin gene expression and biosynthesis in rat sensory neurons during early postnatal development, Neuropeptides, 24 (1993) 351-357.
29. Verge, V.M., Richardson, P.M., Benoit, R. and Riopelle, R.J., Histochemical characterization of sensory neurons with high affinity receptors for nerve growth factor, J. Neurocytol., 18 (1989) 583-591.
30. Weskamp, G. and Otten, J., An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying mechanisms involved in NGF production in brain and in peripheral tissues, J. Neurochem., 48 (1987) 1779-1786.
31. Woolf, C.J., Safieh-Garabedian, B., Ma, Q-P., Crilly, P. and Winter, J., Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity, Neuroscience, 62 (1994) 327-331.
32. Xu, X.J., Dalsgaard, C.J., Maggi, C.A. and Wiesenfeld-Hallin, Z., NK-1 but not NK-2 tachykinin receptors mediate plasma extravasation induced by antidromic C-fiber stimulation in the rat hindpaw - demonstrated with the NK-1 antagonist CP-96,345 and the NK-2 antagonist MEN-10207, Neurosci. Lett., 139 (1992) 249-252.